Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.78
+0.41 (1.75%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Tango Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $45.18. The average 1-year stock price forecast is 89.99% higher than the current stock price, while the lowest is $24 (+0.93%) and the highest is $69 (+190.16%).
Price Target: $45.18 (+89.99%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tango Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 9 | 11 | 11 | 11 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 3 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $46 | Buy | Maintains | $46 | +93.44% | Sep 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $66 → $68 | Buy | Reiterates | $66 → $68 | +185.95% | Aug 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $40 | Buy | Maintains | $40 | +68.21% | Aug 17, 2026 |
| Wedbush | Wedbush | Buy Reiterates $33 → $39 | Buy | Reiterates | $33 → $39 | +64.00% | Aug 12, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $32 → $35 | Buy | Reiterates | $32 → $35 | +47.18% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
from 62.38M
Decreased by -100.00%
Revenue Next Year
2.86M
EPS This Year
-1.39
from -0.87
EPS Next Year
-1.67
from -1.39
EPS and Forward PE are based on non-GAAP adjusted numbers.